Drug labeling is the most important tool for controlling the movement of medicines

through all supply chains from the manufacturer, distribution structure, pharmacies and

medical organizations to the end point - the patient, and an important step towards the

digital economy. The introduction of mandatory labeling and traceability will make the

circulation of medicines more transparent and is one of the main tools for protecting

against the circulation of counterfeit and falsified products, providing the buyer with the

opportunity to independently check the purchased drugs for authenticity, significantly

reducing the costs of "flow" of medicines, simplifying the consolidation of information on

the balance of medicines, and also providing piece-by-piece accounting of individual

packaging from the manufacturer to the patient.

In general, the introduction of labeling for the traceability of goods in Kazakhstan is

carried out within the framework of the Agreement on Labeling Goods with Identification

Means in the EAEU, as well as the Law of the Republic of Kazakhstan “On Regulation of

Trading Activities”, which came into force in the spring of 2019.